Defueling the cancer: ATP synthase as an emerging target in cancer therapy
Ting Wang, Fei Ma, Haili Qian
Abstract
Reprogramming of cellular metabolism is a hallmark of cancer. Mitochondrial ATP synthase (MAS) produces most of the ATP that drives the cell. High expression of the MAS-composing proteins is found during cancer and is linked to a poor prognosis in glioblastoma, ovarian cancer, prostate cancer, breast cancer, and clear cell renal cell carcinoma. Cell surface-expressed ATP synthase, translocated from mitochondrion to cell membrane, involves the angiogenesis, tumorigenesis, and metastasis of cancer. ATP synthase has therefore been considered a therapeutic target. We review recent various ATP synthase inhibitors that suppress tumor growth and are being tested for the clinic.
Topics & Concepts
ATP synthaseCancerCancer therapyCancer researchMedicineBiologyInternal medicineEnzymeBiochemistryATP Synthase and ATPases ResearchRNA modifications and cancerCancer, Hypoxia, and Metabolism